When was Supira Medical founded?

Supira Medical was founded in 2016 and raised its 1st funding round 2 years after it was founded.

Where is Supira Medical located?

Supira Medical is headquartered in Campbell, United States.

How many employees does Supira Medical have?

As of Jun 30, 2026, the latest employee count at Supira Medical is 139.

Is Supira Medical a funded company?

Supira Medical is a funded company, having raised a total of $240M across 5 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Jun 13, 2018.

When was the latest funding round of Supira Medical?

Supira Medical's latest funding was a $***** Series E round on Mar 25, 2025, with participation from 8 investors. Its primary sector is Cardiac and Vascular Disorders. In United States, the Cardiac and Vascular Disorders sector has seen $765M in funding in 2026 to date.

Where does Supira Medical rank among its competitors?

Supira Medical ranks 3rd amongst 64 active competitors, of which 16 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was SIS Medical, which secured an undisclosed amount in Jan, 2026.

Who are the top competitors of Supira Medical?

Supira Medical's top competitors include Silk Road Medical, AVS Pulse and SIS Medical. Among them, SIS Medical secured the most recent funding round in January, 2026.

Supira Medical - 2026 Company Profile, Team, Funding & Competitors

Supira Medical is a series E company based in Campbell (United States), founded in 2016. It operates as a Developer of ventricular assist devices for coronary intervention and cardiogenic shock. Supira Medical has raised $240M in funding from investors like The Capital Partnership, Cormorant Asset Management and Qatar Investment Authority. The company has 64 active competitors, including 16 funded and 14 that have exited. Its top competitors include companies like Silk Road Medical, AVS Pulse and SIS Medical.

Company Details

Developer of ventricular assist devices for coronary intervention and cardiogenic shock. The company has developed solutions for temporary mechanical circulatory support percutaneous ventricular assist devices. It has a feature that maintains the native pumping action of the heart. It provides real-time data about pump performance and location and minimizes vascular complications for patients with coronary artery disease.

Website: supiramedical.com
Email ID: *****@supiramedical.com
Part Of

Key Metrics

Founded Year

2016

Location

Campbell, United States

Stage

Series E

Total Funding

$240M in 5 rounds

Latest Funding Round

Series E, Mar 25, 2025, $*****

Investors

The Capital Partnership & 10 more

Ranked

3^rd among 64 active competitors

Employee Count

139 as on Jun 30, 2026

Similar Companies

Silk Road Medical & 85 more

View Supira Medical's full profile

Supira Medical is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Supira Medical, Inc. CIN: 3968417 , United States, Active	Dec 11, 2020	-	-	-

Supira Medical has raised a total funding of $240M over 5 rounds. Its first funding round was on Jun 13, 2018. Its latest funding round was a Series E round on Mar 25, 2025 for $*****. 8 investors participated in its latest round. Supira Medical has 11 institutional investors.

Here is the list of recent funding rounds of Supira Medical:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 25, 2025	6525158	Series E	7835046	3991878	7467159	2291212
Nov 17, 2023	5049458	Series D	3863275	3530745	9707309	415 CAPITAL & 4 more
Feb 28, 2022	4261508	Series C	9065569	6023532	The Capital Partnership & 1 more	Shifamed & 3 more

Access funding benchmarks and valuations. Sign up today!

View details of Supira Medical's funding rounds and investors

Supira Medical's Board of Directors

Supira Medical's board has 7 active members. Bihua Chen, Christopher Shen, Amr Salahieh, Jean Orth, Mariam Maghribi, Casey Gordon and Nitin Salunke are independent board members.

Here is the list of Supira Medical's board of directors:

Name	Type	Representing	Status	Duration
Bihua Chen	Independent board member	-	Current	6y 4m
y{um{ja	Independent board member	-	Current	7y 3m
xyqguqi	Independent board member	-	Current	7y 2m
do{cimz	Independent board member	-	Current	1y 7m
pdnxxcs	Independent board member	-	Current	7y 6m
tfchuno	Independent board member	-	Current	3y 6m
{nopb{p	Independent board member	-	Current	5y 2m

Supira Medical's employee count trend

Supira Medical has 139 employees as of Jun 26. Here is Supira Medical's employee count trend over the years:

Uncover Supira Medical's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Supira Medical include Silk Road Medical, AVS Pulse and SIS Medical. Here is the list of Top 10 competitors of Supira Medical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Silk Road Medical 2007, Sunnyvale (United States), Acquired	Provider of neuroprotection devices for carotid artery disease	$189M	Norwest, CRG & 2 others	63/100
2nd	AVS Pulse 2017, Ann Arbor (United States), Acquired	Developer of a medical device to treat severely calcified arterial disease	$70.4M	BioStar Capital, Cue Growth Partners & 1 others	59/100
3rd	Supira Medical 2016, Campbell (United States), Series E	Developer of ventricular assist devices for coronary intervention and cardiogenic shock	$240M	Qatar Investment Authority, Cormorant Asset Management ... & 9 others	58/100
4th	SIS Medical 2006, Winterthur (Switzerland), Late Stage	Distributor of medical and surgical supplies	-	Claret Capital Partners, SHS	47/100
5th	CardiacBooster 2018, Nijmegen (Netherlands), Funding Raised	Provider of percutaneous left ventricular assist devices	-	Thuja Capital, Lightstone Ventures & 3 others	47/100
6th	Protaryx Medical 2019, Baltimore (United States), Series A	Developer of smart medical devices for the treatment of atrial septum of the heart diseases	$8.3M	Ajax Health, UM Ventures	47/100
7th	AMT Medical 2016, Utrecht (Netherlands), Series B	Providing solutions for heart bypass surgery	$36.7M	Benderanalyticalholding, Invest-NL & 7 others	43/100
8th	Vascular Graft Solutions 2009, Tel Aviv (Israel), Series B	External support technology to improve vein graft longevity and improve outcome of Cardiac bypass surgery.	$10.7M	Broadview Ventures, GEOC & 5 others	41/100
9th	Shanghai Baixin'an Biotechnology 2014, Pudong (China), Public	Developer of coronary stent system	$15.8M	Qianhai Ark Asset Management, Shanghai Zhangjiang Technology Venture Capital ... & 4 others	40/100
10th	OrbusNeich 2005, Hong Kong (China), Public	Vascular intervention product - Stents and Balloons	-	CEC Capital	40/100